After the success of targeting PD-1/PD-L1 axes, extensive efforts were directed to explore bsAb-based strategies to increase the anti-tumor activity of the adoptively transferred Vγ2Vδ2 T cells (13, 14). Here, CD274 is linked to neoplasm.